Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
49,633,071
-
Total 13F shares
-
30,286,741
-
Share change
-
-2,904,846
-
Total reported value
-
$92,179,926
-
Put/Call ratio
-
50%
-
Price per share
-
$3.04
-
Number of holders
-
96
-
Value change
-
-$39,504,988
-
Number of buys
-
52
-
Number of sells
-
67
Institutional Holders of PUMA BIOTECHNOLOGY, INC. - Common Stock (PBYI) as of Q4 2021
As of 31 Dec 2021,
PUMA BIOTECHNOLOGY, INC. - Common Stock (PBYI) was held by
96 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
30,286,741 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., GOLDMAN SACHS GROUP INC, Camber Capital Management LP, RENAISSANCE TECHNOLOGIES LLC, ACADIAN ASSET MANAGEMENT LLC, MILLENNIUM MANAGEMENT LLC, Eversept Partners, LP, JACOBS LEVY EQUITY MANAGEMENT, INC, and D. E. Shaw & Co., Inc..
This page lists
96
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.